AnnouncementsAwards and HonorsCommunityInnovationNews

CellNetix Launches COVID-19 Testing Services

CellNetix Pathology & Laboratories is proud to announce the launch of SARS CoV-2 TMA testing. Given the surge of Omicron COVID cases and the challenges in finding testing facilities, CellNetix is excited to partner with clients, as well as businesses and organizations to meet their testing needs.

SARS-CoV-2 TMA assay is a highly sensitive molecular test that targets and detects the RNA molecule in upper respiratory specimens for the diagnosis of COVID-19 in symptomatic and asymptomatic individuals. Utilizing Transcription Mediated Amplification technology on the Hologic Panther, this test is approved for use under an Emergency Use Authorization. The turnaround time is 24-48 hours. To learn more, visit the COVID Testing webpage.

More Articles